Dr. McCarter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
One Boston Medical Center Pl
Boston, MA 02118
Education & Training
- Brigham and Women's HospitalFellowship, Rheumatology, 2024 - 2026
- Boston University Medical CenterResidency, Internal Medicine, 2018 - 2021
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2018
- Boston CollegeBA, Philosophy, 2007 - 2011
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- MA State Medical License 2018 - 2026
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort study.Kathleen M M Vanni, Kaitlin R McCarter, Xiaosong Wang, Caitlyn Duffy, Jamie P Dela Cruz
The Lancet. Rheumatology. 2025-01-28 - 4 citationsImmunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for ca...Kaitlin R McCarter, Senada Arabelovic, Xiaosong Wang, Taylor Wolfgang, Kazuki Yoshida
Seminars in Arthritis and Rheumatism. 2024-02-01 - 10 citationsMortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: a retrospect...Kaitlin R McCarter, Taylor Wolfgang, Senada Arabelovic, Xiaosong Wang, Kazuki Yoshida
The Lancet. Rheumatology. 2023-05-01
Press Mentions
- Cancer Drug Okay in Rheumatoid ArthritisApril 17th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: